Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

PHGDH promotes cancer growth by aiding cell proliferation and tumor progression.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Enzymes called PADIs play a key role in hair growth and loss.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.

The Walleye dermal sarcoma virus cyclin causes excessive skin cell growth in mice.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Twist1 is crucial for UVB-induced skin cancer development.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

QLT0267 stops hair follicle cell growth and movement.

Wnt/ß-catenin signaling is crucial for regulating skin stem cells and hair growth, with the right levels and timing needed for proper function.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

The circadian clock affects skin stem cell behavior, impacting aging and cancer risk.

Keratins 6, 16, and 17 increase in damaged or diseased skin and may help diagnose skin issues.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Hair shaft changes may be linked to CCCA, but their role is unclear.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.